In this issue:
Metabolic response and renal risk after bariatric surgery in type 2 diabetes subgroups
Effects of tirzepatide on pancreatic islet function and insulin sensitivity in type 2 diabetes
Tirzepatide vs. insulin degludec on CGM-measured glycaemic control in type 2 diabetes
Tirzepatide vs. insulin degludec on liver fat and abdominal adipose tissue in type 2 diabetes
Risks and burdens of incident diabetes in long COVID
Diabetes incidence after recent SARS-COV-2 infection
Predictors of glycaemic control deterioration in youth-onset type 2 diabetes
Dapagliflozin in children and young adults with type 2 diabetes
Association of BMI in adolescence with type 2 diabetes risk
Semaglutide in east Asian overweight/obese adults
Please login below to download this issue (PDF)